Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors
- 9 January 2004
- journal article
- research article
- Published by Walter de Gruyter GmbH in cclm
- Vol. 42 (3), 323-33
- https://doi.org/10.1515/cclm.2004.058
Abstract
Combinations of tests comprising αKeywords
This publication has 32 references indexed in Scilit:
- Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patientsAIDS, 2003
- Noninvasive monitoring of patients with chronic hepatitis CHepatology, 2002
- Matrix Metalloproteinase-9 and Tissue Inhibitors of Matrix Metalloproteinase-1 in Plasma of Patients Co-Infected with HCV and HIVHIV Research & Clinical Practice, 2002
- Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective studyThe Lancet, 2001
- Practices of Liver Biopsy in France: Results of a Prospective Nationwide SurveyHepatology, 2000
- Rat hepatic stellate cell expression of α2-macroglobulin is a feature of cellular activation: implications for matrix remodelling in hepatic fibrosisClinical Science, 1998
- Transforming growth factor-β-induced collagen synthesis by human liver myofibroblasts is inhibited by α2-macroglobulinJournal of Hepatology, 1997
- Haptoglobin polymorphism and chronic hepatitis CJournal of Hepatology, 1996
- Intraobserver and Interobserver Variations in Liver Biopsy Interpretation in Patients With Chronic Hepatitis CHepatology, 1994
- SAMPLING VARIABILITY AND ITS INFLUENCE ON THE DIAGNOSTIC YIELD OF PERCUTANEOUS NEEDLE BIOPSY OF THE LIVERThe Lancet, 1986